Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Vycor Medical, Inc./ 10-K

Annual Report · 10-K

Vycor Medical, Inc.

VYCOOTCEQUITYCurrent

Annual Report

Filed Apr 15, 2025Accepted Apr 15, 2025, 9:54 AM EDTCIK 1424768Accession 0001641172-25-004744
View company →Permanent SEC source ↗
Share

Company context

With corporate headquarters in Boca Raton, FL, Vycor Medical, Inc. (“Vycor”) is a publicly traded company (OTCQB:VYCO) dedicated to providing the medical community with innovative and superior surgical and therapeutic solutions and has a growing portfolio of FDA cleared or registered medical solutions that are changing and improving lives every day. The Company operates two business units: Vycor Medical and NovaVision, both of which adopt a minimally or non-invasive approach.

Current securities

VYCOOTC · EQUITY · Current

Recent company filings

  1. Results of Operations and Financial ConditionAug 14, 2026
  2. 10-Q filingAug 14, 2026
  3. Results of Operations and Financial ConditionMay 15, 2026
  4. 10-Q filingMay 15, 2026
  5. Results of Operations and Financial ConditionMar 31, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗